Integral Diagnostics Ltd. (AU:IDX)
ASX:IDX
Want to see AU:IDX full AI Analyst Report?
IDX Stock Chart & Stats
AU$2.26
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$2.26
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$2.17 - AU$3.07
Previous CloseN/A
Volume920.11K
Average Volume (3M)911.20K
Market Cap
AU$831.46M
Enterprise ValueAU$1.63B
Total Cash (Recent Filing)AU$34.12M
Total Debt (Recent Filing)AU$841.54M
Price to Earnings (P/E)26.4
Beta0.48
Next Earnings
Aug 31, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend Yield2.65%
Share Statistics
EPS (TTM)0.02
Shares Outstanding373,066,530
10 Day Avg. Volume1,057,226
30 Day Avg. Volume911,197
Financial Highlights & Ratios
PEG Ratio-1.57
Price to Book (P/B)1.12
Price to Sales (P/S)1.24
P/FCF Ratio55.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.25Price Target Upside43.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.13
Revenue Forecast (FY)AU$801.31M
Bulls Say, Bears Say
Bulls Say
Network-based Imaging PlatformA broad clinic and hospital network creates durable referral pipelines and diversified site mix across community and hospital settings. This scale supports consistent patient volumes, more efficient equipment utilization and long-term contractual relationships with hospitals and clinicians.
Strong Revenue GrowthSustained high revenue growth indicates rising demand for imaging services and successful expansion or utilization of capacity. Over 2-6 months this supports investment prioritization, helps absorb fixed costs, and provides a foundation to improve operating leverage and margin conversion over time.
High Gross MarginVery high gross margin implies the core service business is highly profitable before overhead, reflecting pricing power or low direct cost per scan. This structural cost profile gives room to fund SG&A and capex while preserving operating leverage as volumes grow, supporting long-term margin resilience.
Bears Say
Weak Net ProfitabilityDespite strong top-line and gross margins, near-zero net margins point to elevated operating, depreciation or financing costs that erode shareholder returns. Persistently low net profit limits retained earnings, dividend capacity and reinvestment potential unless cost structure or pricing improves.
Declining Free Cash FlowA large drop in free cash flow reduces internal funding for capex, debt reduction and acquisitions. If the trend continues it pressures liquidity and forces reliance on external financing, undermining the company's ability to sustainably support network expansion and absorb unexpected shocks.
Low Return On EquityVery low ROE indicates limited effectiveness turning shareholder capital into profits. Over months this signals potential inefficiencies in capital allocation or an asset-heavy, low-return structure, constraining the company's ability to generate attractive long-term shareholder value without strategic changes.
Integral Diagnostics Ltd. News
IDX FAQ
What was Integral Diagnostics Ltd.’s price range in the past 12 months?
Integral Diagnostics Ltd. lowest share price was AU$2.17 and its highest was AU$3.07 in the past 12 months.
What is Integral Diagnostics Ltd.’s market cap?
Integral Diagnostics Ltd.’s market cap is AU$831.46M.
When is Integral Diagnostics Ltd.’s upcoming earnings report date?
Integral Diagnostics Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 124 days.
How were Integral Diagnostics Ltd.’s earnings last quarter?
Integral Diagnostics Ltd. released its earnings results on Feb 23, 2026. The company reported AU$0.024 earnings per share for the quarter, missing the consensus estimate of AU$0.056 by -AU$0.032.
Is Integral Diagnostics Ltd. overvalued?
According to Wall Street analysts Integral Diagnostics Ltd.’s price is currently Undervalued.
Does Integral Diagnostics Ltd. pay dividends?
Integral Diagnostics Ltd. pays a Semiannually dividend of AU$0.04 which represents an annual dividend yield of 2.65%. See more information on Integral Diagnostics Ltd. dividends here
What is Integral Diagnostics Ltd.’s EPS estimate?
Integral Diagnostics Ltd.’s EPS estimate is 0.07.
How many shares outstanding does Integral Diagnostics Ltd. have?
Integral Diagnostics Ltd. has 373,066,530 shares outstanding.
What happened to Integral Diagnostics Ltd.’s price movement after its last earnings report?
Integral Diagnostics Ltd. reported an EPS of AU$0.024 in its last earnings report, missing expectations of AU$0.056. Following the earnings report the stock price went down -5.83%.
Which hedge fund is a major shareholder of Integral Diagnostics Ltd.?
Currently, no hedge funds are holding shares in AU:IDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integral Diagnostics Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$3.25 (43.95% Upside)
AU$3.25 (43.95% Upside)
Blogger Sentiment
Bullish
AU:IDX Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$170.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.34%
12-Months-Change
Fundamentals
Return on Equity
2.05%
Trailing 12-Months
Asset Growth
4.81%
Trailing 12-Months
Company Description
Integral Diagnostics Ltd.
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
IDX Stock 12 Month Forecast
Average Price Target
AU$3.25
▲(43.95% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Sonic Healthcare Limited
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---